Gigantomastia: Advancing a Preference Score System to Enhance Care Quality and Life Standards.

Background: This study introduces a new Gigantomastia Preference Score (GPS) to prioritize surgical candidates based on clinical severity and quality of life impact.

Methods: This retrospective study applied the newly developed GPS to the existing surgery waiting list of 213 patients at our center. The GPS was developed from evidence-based clinical practice indicators and a thorough literature review, selecting nine variables. The GPS was then used to reorder the waiting list, and comparisons were made between the original and reordered lists.

Results: Implementation of the GPS significantly reordered the waiting list. The Spearman's Rank Correlation coefficient between the original and new rankings was 0.5679 (p-value = 1.38e-19), indicating a moderate to strong positive correlation. The Wilcoxon Signed-Rank Test yielded a statistic of 3485.0 (p-value = 8.44e-21), showing significant changes in patient positions. ANOVA results highlighted significant differences in BMI and largest breast weight across priority levels. Chi-Square tests revealed significant associations between priority levels and Trauma and Psychiatry reports.

Conclusions: The GPS significantly improved the prioritization of patients with gigantomastia by incorporating multiple clinically relevant factors. This led to a more equitable and informed ordering of the surgical waiting list, potentially improving patient outcomes and optimizing healthcare resource allocation.

Level of evidence iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors   www.springer.com/00266 .